Pub Date : 2024-10-24DOI: 10.1016/j.recesp.2024.05.012
{"title":"Tres parejas que se parecen, pero no son lo mismo","authors":"","doi":"10.1016/j.recesp.2024.05.012","DOIUrl":"10.1016/j.recesp.2024.05.012","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 11","pages":"Pages 879-880"},"PeriodicalIF":5.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142526472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-26DOI: 10.1016/j.recesp.2024.04.001
Fernando A. Navarro
{"title":"FAST en el ictus (y III)","authors":"Fernando A. Navarro","doi":"10.1016/j.recesp.2024.04.001","DOIUrl":"10.1016/j.recesp.2024.04.001","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 10","pages":"Pages 803-804"},"PeriodicalIF":5.9,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142322584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-26DOI: 10.1016/j.recesp.2023.09.011
Fernando A. Navarro
{"title":"FAST en el ictus (II)","authors":"Fernando A. Navarro","doi":"10.1016/j.recesp.2023.09.011","DOIUrl":"10.1016/j.recesp.2023.09.011","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 9","pages":"Page 709"},"PeriodicalIF":5.9,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142077253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-13DOI: 10.1016/j.recesp.2024.08.001
Joaquín Osca Asensi , Ignacio Fernández Lozano , Javier Alzueta Rodriguez , David Calvo
Introduction
This article presents data on implantable cardioverter-defibrillator implants in Spain in 2023.
Methods
The registry is based on information provided by centers following device implantation, which is submitted to the Heart Rhythm Association of the Spanish Society of Cardiology via the national online registry platform (Cardiodispositivos). Additional information sources include: a) data transfer from the manufacturing and marketing industry; and b) local databases sent from the implanting centers. Population data from the National Institute of Statistics for the first quarter of 2024 was used to calculate implant rates.
Results
In 2023, 180 hospitals participated in the registry. Data were reported for 8219 units, compared with 8523 reported by Eucomed (European Confederation of Medical Suppliers Associations). The total implant rate was 172 implants per million inhabitants (177 according to Eucomed), representing an increase compared with previous years. However, differences among autonomous communities persisted, and Spain continues to have the lowest implant rate among the European countries participating in Eucomed.
Conclusions
The data from the 2023 registry reflects 96.4% of the implants performed in Spain. Despite the improvement observed in the implantation rate, Spain's position in Europe remains unchanged, with wide disparities among autonomous communities.
导读：本文介绍了 2023 年西班牙植入式心律转复除颤器的数据。方法该登记基于各中心在设备植入后提供的信息，这些信息通过国家在线登记平台（Cardiodispositivos）提交给西班牙心脏病学会心律协会（Heart Rhythm Association of the Society of Cardiology）。其他信息来源包括：a) 来自制造和营销行业的数据传输；b) 来自植入中心的本地数据库。国家统计局提供的 2024 年第一季度人口数据用于计算植入率。共报告了 8219 台设备的数据，而欧洲医疗供应商协会联合会（Eucomed）报告的数据为 8523 台。总植入率为每百万居民 172 例（根据 Eucomed 的数据为 177 例），与前几年相比有所增加。结论 2023 年登记册的数据反映了西班牙 96.4% 的植入手术。尽管植入率有所提高，但西班牙在欧洲的地位仍未改变，各自治区之间的差距很大。
{"title":"Registro español de desfibrilador automático implantable. XX informe oficial de la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología (2023)","authors":"Joaquín Osca Asensi , Ignacio Fernández Lozano , Javier Alzueta Rodriguez , David Calvo","doi":"10.1016/j.recesp.2024.08.001","DOIUrl":"10.1016/j.recesp.2024.08.001","url":null,"abstract":"<div><h3>Introduction</h3><div>This article presents data on implantable cardioverter-defibrillator implants in Spain in 2023.</div></div><div><h3>Methods</h3><div>The registry is based on information provided by centers following device implantation, which is submitted to the Heart Rhythm Association of the Spanish Society of Cardiology via the national online registry platform (Cardiodispositivos). Additional information sources include: <em>a)</em> data transfer from the manufacturing and marketing industry; and <em>b)</em> local databases sent from the implanting centers. Population data from the National Institute of Statistics for the first quarter of 2024 was used to calculate implant rates.</div></div><div><h3>Results</h3><div>In 2023, 180 hospitals participated in the registry. Data were reported for 8219 units, compared with 8523 reported by Eucomed (European Confederation of Medical Suppliers Associations). The total implant rate was 172 implants per million inhabitants (177 according to Eucomed), representing an increase compared with previous years. However, differences among autonomous communities persisted, and Spain continues to have the lowest implant rate among the European countries participating in Eucomed.</div></div><div><h3>Conclusions</h3><div>The data from the 2023 registry reflects 96.4% of the implants performed in Spain. Despite the improvement observed in the implantation rate, Spain's position in Europe remains unchanged, with wide disparities among autonomous communities.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 12","pages":"Pages 1037-1049"},"PeriodicalIF":5.9,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142720604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-06DOI: 10.1016/j.recesp.2024.06.003
Gabriela Tirado-Conte , Ángel Sánchez-Recalde , José Luis Zamorano
{"title":"¿Son los anticoagulantes de acción directa la primera elección en pacientes sometidos a TAVI?","authors":"Gabriela Tirado-Conte , Ángel Sánchez-Recalde , José Luis Zamorano","doi":"10.1016/j.recesp.2024.06.003","DOIUrl":"10.1016/j.recesp.2024.06.003","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 12","pages":"Pages 985-986"},"PeriodicalIF":5.9,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142720609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-06DOI: 10.1016/j.recesp.2024.07.014
Victor Bazan , Eduardo Arana , José Manuel Rubio-Campal , David Calvo , en representación de los colaboradores del Registro español de ablación con catéter
Introduction and objectives
We report the results of the 2023 Spanish catheter ablation registry.
Methods
Procedural data were collected and incorporated into the REDCap platform by all participating centers through a specific form.
Results
There were 104 participating centers in 2023 compared with 103 in 2022. In 2023, the total number of ablation procedures was 26 207, indicating a stabilization of the increase observed in 2022 following the pandemic. The increase was mainly due to procedures for atrial fibrillation (AF), with a total of 9942 ablations, representing 38% of all substrates. Notably, pulse-field ablation represented 10.3% of all AF ablation procedures, leading single-shot ablation strategies to outnumber point-by-point AF ablation for the first time in the history of the registry. Cavotricuspid isthmus ablation remained the second most targeted substrate (19% of all substrates, n = 5067). The overall acute success rate remained high (97%), with a downward trend in the complication rate (1.6% vs 1.8% in 2022) and mortality rate (0.03%; n = 7). Compared with 2022, there was a significant increase in procedures performed using electro-anatomical mapping and zero-fluoroscopy techniques for cavotricuspid isthmus ablation (52% vs 26%), AV node re-entrant tachycardia (48% vs 34%), and accessory pathways (62% vs 22%). We registered 466 ablations in pediatric patients.
Conclusions
The data indicate a stabilization in the post-pandemic increase in ablation procedures, with an absolute and relative increase in AF as the predominant substrate. Success rates remained stable with a modest reduction in complication and mortality rates.
{"title":"Registro español de ablación con catéter. XXIII informe oficial de la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología (2023)","authors":"Victor Bazan , Eduardo Arana , José Manuel Rubio-Campal , David Calvo , en representación de los colaboradores del Registro español de ablación con catéter","doi":"10.1016/j.recesp.2024.07.014","DOIUrl":"10.1016/j.recesp.2024.07.014","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>We report the results of the 2023 Spanish catheter ablation registry.</div></div><div><h3>Methods</h3><div>Procedural data were collected and incorporated into the REDCap platform by all participating centers through a specific form.</div></div><div><h3>Results</h3><div>There were 104 participating centers in 2023 compared with 103 in 2022. In 2023, the total number of ablation procedures was 26 207, indicating a stabilization of the increase observed in 2022 following the pandemic. The increase was mainly due to procedures for atrial fibrillation (AF), with a total of 9942 ablations, representing 38% of all substrates. Notably, pulse-field ablation represented 10.3% of all AF ablation procedures, leading single-shot ablation strategies to outnumber point-by-point AF ablation for the first time in the history of the registry. Cavotricuspid isthmus ablation remained the second most targeted substrate (19% of all substrates, n<!--> <!-->=<!--> <!-->5067). The overall acute success rate remained high (97%), with a downward trend in the complication rate (1.6% vs 1.8% in 2022) and mortality rate (0.03%; n<!--> <!-->=<!--> <!-->7). Compared with 2022, there was a significant increase in procedures performed using electro-anatomical mapping and zero-fluoroscopy techniques for cavotricuspid isthmus ablation (52% vs 26%), AV node re-entrant tachycardia (48% vs 34%), and accessory pathways (62% vs 22%). We registered 466 ablations in pediatric patients.</div></div><div><h3>Conclusions</h3><div>The data indicate a stabilization in the post-pandemic increase in ablation procedures, with an absolute and relative increase in AF as the predominant substrate. Success rates remained stable with a modest reduction in complication and mortality rates.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 12","pages":"Pages 1026-1036"},"PeriodicalIF":5.9,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142720531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.recesp.2024.02.012
{"title":"Utilización del tratamiento antitrombótico periprocedimiento en cardiología intervencionista en España: ¿lo hacemos mejor que en otras especialidades?","authors":"","doi":"10.1016/j.recesp.2024.02.012","DOIUrl":"10.1016/j.recesp.2024.02.012","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 8","pages":"Pages 701-703"},"PeriodicalIF":5.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140468910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.recesp.2024.02.009
Atrial fibrillation (AF) causes progressive structural and electrical changes in the atria that can be summarized within the general concept of atrial remodeling. In parallel, other clinical characteristics and comorbidities may also affect atrial tissue properties and make the atria susceptible to AF initiation and its long-term persistence. Overall, pathological atrial changes lead to atrial cardiomyopathy with important implications for rhythm control. Although there is general agreement on the role of the atrial substrate for successful rhythm control in AF, the current classification oversimplifies clinical management. The classification uses temporal criteria and does not establish a well-defined strategy to characterize the individual-specific degree of atrial cardiomyopathy. Better characterization of atrial cardiomyopathy may improve the decision-making process on the most appropriate therapeutic option. We review current scientific evidence and propose a practical characterization of the atrial substrate based on 3 evaluation steps starting with a clinical evaluation (step 1), then assess outpatient complementary data (step 2), and finally include information from advanced diagnostic tools (step 3). The information from each of the steps or a combination thereof can be used to classify AF patients in 4 stages of atrial cardiomyopathy, which we also use to estimate the success on effective rhythm control.
{"title":"Aproximación práctica para la caracterización de la miocardiopatía auricular en pacientes con fibrilación auricular","authors":"","doi":"10.1016/j.recesp.2024.02.009","DOIUrl":"10.1016/j.recesp.2024.02.009","url":null,"abstract":"<div><p>Atrial fibrillation (AF) causes progressive structural and electrical changes in the atria that can be summarized within the general concept of atrial remodeling. In parallel, other clinical characteristics and comorbidities may also affect atrial tissue properties and make the atria susceptible to AF initiation and its long-term persistence. Overall, pathological atrial changes lead to atrial cardiomyopathy with important implications for rhythm control. Although there is general agreement on the role of the atrial substrate for successful rhythm control in AF, the current classification oversimplifies clinical management. The classification uses temporal criteria and does not establish a well-defined strategy to characterize the individual-specific degree of atrial cardiomyopathy. Better characterization of atrial cardiomyopathy may improve the decision-making process on the most appropriate therapeutic option. We review current scientific evidence and propose a practical characterization of the atrial substrate based on 3 evaluation steps starting with a clinical evaluation (step 1), then assess outpatient complementary data (step 2), and finally include information from advanced diagnostic tools (step 3). The information from each of the steps or a combination thereof can be used to classify AF patients in 4 stages of atrial cardiomyopathy, which we also use to estimate the success on effective rhythm control.</p></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 8","pages":"Pages 656-666"},"PeriodicalIF":5.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S030089322400068X/pdfft?md5=c2a8a2b4fd735a7eba75448a9e0d407a&pid=1-s2.0-S030089322400068X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141027483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-01DOI: 10.1016/j.recesp.2024.02.005
{"title":"Insuficiencia mitral primaria tratada con reparación percutánea de borde a borde: ¿aporta el ecocardiograma transtorácico información pronóstica?","authors":"","doi":"10.1016/j.recesp.2024.02.005","DOIUrl":"10.1016/j.recesp.2024.02.005","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 8","pages":"Pages 632-633"},"PeriodicalIF":5.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140465711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号